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Abstract
The purpose of this ex post facto study was to
determine the effects of antihypertensive and cardiac drugs
on the level of depression in community-based elders.

Roy's

Adaptation Model provided the theoretical framework for this
study.

Data were collected using the Brink Geriatric

Depression Scale and the Drug Information Sheet.

These

questionnaires were administered to 40 subjects ages 55 and
older who were taking antihypertensive and/or cardiac drugs
or neither antihypertensive nor cardiac drugs.
One null hypothesis and five directional hypotheses
guided this study.

The null hypothesis stated that there

would be no difference in mean depression scores among the
following groups:

(a) elders taking neither

antihypertensive nor cardiac drugs,
antihypertensive drugs alone,

(b) elders taking

(c) elders taking cardiac

drugs alone, and (d) elders taking a combination of
antihypertensive and cardiac drugs.

Utilizing the ANOVA,

the result was significant at the .05 level.

Thus, the

researcher rejected the null hypothesis.
Directional hypotheses made the following comparisons
of community-based elders :

Elders who took antihypertensive

drugs only and elders who took no drugs, elders who took
iv

cardiac drugs only and elders who took no drugs, elders who
took antihypertensive and cardiac drugs and elders who took
antihypertensive drugs alone, elders who took
antihypertensive and cardiac drugs and elders who took
cardiac drugs alone, and elders who took antihypertensive
and cardiac drugs and elders who took neither
antihypertensive nor cardiac d r ugs.

Utilizing the t test,

the following comparisons were significant at the .05 level:
Elders who took antihypertensive drugs only and elders who
took no drugs, elders who took cardiac drugs only and elders
who took no drugs, and elders who took antihypertensive and
cardiac drugs and elders who took neither antihypertensive
nor cardiac d r u g s .
The findings of this study indicate that elders who
take antihypertensive and/or cardiac drugs experience a
significantly higher level of depression as compared to
elders who do not take antihypertensive or cardiac drugs.
Pharmacotherapeutic depression may or may not result when
antihypertensive and/or cardiac drugs are ingested.
Perhaps, as a function of the aging process, depression may
be experienced by all elders.

Recommendations for further

study include conduction of a similar study including
chronic illnesses and level of depression and conduction of
a study to determine effects of multiple medication
ingestion and level of depression.
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Chapter I
The Research Problem
Elders constitute about 12% of the population and
consume from 25% to 30% of all prescription drugs in the
United States.

Noninstitutionalized elders take an average

of 5.6 drugs daily, and elders 60 years and over routinely
ingest five or more medications each day (Hawranik &
Kondratuk,

1989; Mullen & Granholm,

1981).

These reports

confirm the extensive drug use by the elderly population.
The two major classes of pharmacologic agents most often
prescribed for elders are cardiac and antihypertensive.
Many of the drugs in these categories have the known side
effect of depression which places the elder at risk to
develop iatrogenically-induced depression.

Since no

research has examined the correlation of usage of selected
pharmacologic agents and level of depression in elders, this
study sought to determine if such a link existed.
Introduction to the Problem
Depression has been referred to as the common cold of
elderly persons and has been reported as affecting from 10%
to 70% of elders

(Ebersole & Hess,

1985).

At least 15% of

all elders diagnosed as being depressed show signs of

2
cognitive impairment and other indications of dementia
placing them at risk for being misdiagnosed as senile.
Misdiagnoses and mistreatment of depression in elders result
in severe disability, such as immobility,

fecal impaction,

incontinence, clouding of consciousness, and even death
(Breslau & Haug,

1983; Hawranik & Kondratuk,

1989).

Suicide, the most serious yet preventable consequence
of depression, has an alarmingly high rate among the elderly
population.

Hawranik and Kondratuk (1989)

found that 28% of

all suicides are committed by people over the age of 60, and
at least one half of those who committed suicide suffered
from depression.

The suicide rate for elderly males is the

highest of any age group.

Among males over the age of 80,

the rate approaches 50 per 100,000 as compared to 10 per
100,000 for the general population (Kane, Ouslander, &
Abrass,

1989).

Depression also affects the elder's functioning in
performance of activities of daily living since depression
depletes energy levels.

When this depression is combined

with feelings of low self-esteem, the elder is unable to
mobilize enough energy to care for himself.

The depressed

elder may regress to the point of self-neglect and refuse to
bathe, shave, or eat (Breslau & Haug,

1983).

The larger societal issue of depression in elders is
never fully considered.

Since many treatable depressed

elders do not receive formal diagnosis and intervention.
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they often become chronically depressed and disabled.

The

economic costs of long-term care for these people, whether
in a nursing home or within the family setting, can become
an enormous social burden (Breslau & Haug,

1983).

The connection between depression and prescription
drugs was highlighted with the widespread use of the
antihypertensive drug reserpine.

Depression was recognized

as a side effect of reserpine because of the high number of
people who became depressed after taking this agent.
antihypertensive drugs

Other

(clonidine, hydralazine, methyldopa,

propranolol), benzodiazepines,

levodopa, digitalis,

indomethacin, corticosteroids, and phenothiazines have been
reported to cause depression.

These agents are some of the

most commonly prescribed drugs for elderly persons.

Other

drugs that predispose the elder to psychiatric reactions,
including depression, are female hormones and agents to
treat Parkinson's disease, tuberculosis, and cancer (Breslau
& Haug,

1983).

Of all drugs taken by elders, antihypertensive drugs
are most likely to induce a true depression.

Up to 2 0% of

all elders treated with antihypertensive drugs manifest
symptoms of depression including sadness, weakness, apathy,
agitation, and insomnia (Breslau & Haug,

1983).

In summary, depression has been found to be a
significant health problem in the elderly population.

This

population has been consuming large amounts of medications.
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many of which have the side effect of depression.
Therefore,

iatrogenically-induced depression may be common.

Consequences of depression included impaired cognitive
functioning,

suicide,

inability to perform activities of

daily living, and societal burden.

Further research is

needed to assess level of depression and drug ingestion by
elders.
Significance to Nursing
The need for this study was based on the practice of
the Geriatric Nurse Clinician (GNC) who is in a unique
position to assess and manage depression in elders.

The GNC

can prescribe medication for elders in collaboration with a
physician.

Since certain drugs have the known side effect

of depression, discretion can be used in prescribing and
monitoring those d r u g s .

These actions may then decrease

the incidence of depression in elders leading to a decrease
in health problems caused by depression, an overall
improvement in the health status of elders, and a better
quality of life for elders.

The GNC also serves as teacher

and consultant to other health care providers by providing
them with the knowledge necessary in prescribing therapeutic
regimens designed to decrease the incidence of depression in
elders.

Theoretical Framework
Roy's Adaptation Model provided the necessary
theoretical framework to assess and treat
pharmacotherapeutic depression in the elderly.

According to

Riehl and Roy (1980), a positive response to a changing
environment is the process of adaptation.

Depression caused

by medications indicates adaptation failure.
Man is viewed as a biopsychosocial being in constant
interaction with a changing environment.

The anatomical

parts of man function physiologically to contribute to
biological constancy of man.
nature.

Man also has a psychologic

The biological system and the nervous system

produce meaningful behavior.

Therefore, behavior or

biologic and psychologic constancy can be affected by
environmental stimuli such as pharmacotherapeutic agents.
Environment may be defined as "all conditions,
circumstances, and influences surrounding and affecting the
development and behavior of persons or groups"
1989, p. 314).

(Fawcett,

One factor in the environment of elders is

pharmacotherapeutic agents.

Factors in the environment that

affect the elder are focal, contextual, or residual stimuli.
Pharmacotherapeutic agents are focal stimuli confronting the
person.
Health is viewed as a continuum from maximum wellness
to maximum illness.

As the person moves along the

continuum, adaptation problems are encountered.

Health
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results when the person adapts successfully to environmental
demands.

An adaptive response in general is behavior that

maintains the integrity of the individual;

t hus, a

maladaptive response is one that does not maintain the
integrity of the individual.

Depression is a maladaptive

response that does not maintain the integrity of the
individual.

The p e r s o n ’s coping mechanisms may be

categorized as the regulator subsystem or cognator
subsystem.

The regulator mechanisms work mainly through

the autonomic nervous system which readies the person for
coping with stimuli by approach, attack, or flight.

The

cognator mechanisms identify, store, and relate stimuli so
symbolic responses can be made.

Depression could affect

the regulator and cognator adaptive mechanisms.

Pronounced

autonomic activity with cognator ineffectiveness signals
an adaptation failure.

Thus, depression caused by

pharmacotherapeutic agents, or iatrogenically-induced
depression,

signifies adaptation failure.

The focus of nursing, according to Riehl and Roy (1980)
is on the person as a total being at a point along the
health-illness continuum.

Nursing is needed when unusual

stresses or weakened coping mechanisms make the person's
usual attempts to cope ineffective.

The goals of nursing

are to promote client adaptation in all four adaptive modes
(physiologic,

self-concept, role function, and

interdependence) during health and illness.

The physiologic

7
mode has as its basis man's need for physiologic integrity.
The self-concept mode is composed of the physical self and
the personal self.

The role function mode and the

interdependence mode are related to the need for social
integrity.

Man needs to know who he is in relation to

others and what the expectations of society are regarding
the position he holds so he can act appropriately.

An

internal or external change may affect more than one
adaptive mode at a time.

The complexity and

interrelatedness of the total person must be kept in mind
as the nurse views man.

Therefore, depression affects

man's functioning in all modes.
comprised,

Physiologic integrity is

self-esteem is lowered, and role expectations and

interdependence needs are not fulfilled (Fawcett,
Marriner,

1986; Riehl & Roy,

1989;

1980).

Assumptions
This study was based on the assumption that
iatrogenically-induced depression is a result of ingestion
of antihypertensive and cardiac drugs, and depression is a
syndrome that can be measured.
Statement of the Problem
This study addressed the question:

What is the effect

of antihypertensive and cardiac drugs on the level of
depression in community-based elders?
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Research Hypotheses
The research hypotheses that guided this study are as
follows :
Ho:

There will be no difference in mean depression

scores among the following groups :

Group l--elders taking

neither antihypertensive nor cardiac drugs. Group 2--elders
taking antihypertensive drugs only. Group 3--elders taking
cardiac drugs only, and Group 4 --elders taking a combination
of antihypertensive and cardiac drugs.
Ha^:

Community-based elders who take antihypertensive

drugs will experience a significantly higher level of
depression than elders who do not take antihypertensive and
cardiac d r u g s .
Ha^ :

Community-based elders who take cardiac drugs

will experience a significantly higher level of depression
than elders who do not take antihypertensive and cardiac
drugs.
Ha^ :

Community-based elders who take antihypertensive

and cardiac drugs will experience a significantly higher
level of depression than those elders taking
antihypertensive drugs alone.
Ha^:

Community-based elders who take antihypertensive

and cardiac drugs will experience a significantly higher
level of depression than those elders taking cardiac drugs
alone.
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Ha^:

Community-based elders who take antihypertensive

and cardiac drugs will experience higher level of depression
than those elders taking neither antihypertensive nor
cardiac d r u g s .
Definition of Terms
For the purpose of this research the following defini
tions were used;
Community-based elders ;

Those males and females 55 and

older living in the community who are taking only antihyper
tensive drugs, only cardiac drugs, both antihypertensive and
cardiac drugs, or neither antihypertensive nor cardiac
drugs.
Antihypertensive drugs :

Drugs taken to control blood

pressure including antiadrenergics, peripheral vasodilators,
beta-adrenergic blocking agents, and central alphaadrenergic agonists.
Cardiac drugs :

Drugs taken for any heart condition

including coronary vasodilators, antidysrhythmics, and
cardiac glycosides.
Level of depression:

A syndrome consisting of lowered

mood tone, difficulty in thinking, and somatic changes as
measured by the Brink Geriatric Depression Scale (1983).

Chapter II
Review of the Literature
Although specific drugs have been identified as causing
the side effect of depression, only one study was found with
the specific purpose of identifying drugs that were
significantly related to depression.

Therefore, the

emphasis of this literature review is the epidemiology of
depression in the elderly community.
Blazer and Williams

(1980) conducted a descriptive

study designed to establish the prevalence of dysphoric
symptoms and the symptoms of major depressive disorders in
an elderly community population.

The authors surveyed 997

elderly people living independently in the community.

The

sample consisted of elders 65 and older, with the average
age being 74 years.

Methods of data collection included

symptom checklists and interviews.

The instrument used to

collect data was a checklist for dysphoric symptoms using
the operational criteria established by DSM-III for
psychiatric diagnoses.
Data were analyzed using frequency distributions.
rate of significant dysphoric symptomatology was 14.7%.
Forty-five of these individuals suffered from dysphoric
10

The
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symptoms only, and 37 had symptoms of a major depressive
disorder.

Eighteen suffered from symptoms of primary

depressive disorder and 19 from symptoms of secondary
depressive disorder.
symptoms,

Of the 147 subjects with depressive

65 (44%) had physical health impairment.

frequency of widowhood,

The

impairment in social resources, and

impairment in economic resources was greater for individuals
with symptoms of a major depressive disorder.
The findings in this study confirm previous reports
that the prevalence of depressive symptomatology is quite
high among elderly persons in the community.

However, the

prevalence of the symptoms of primary depressive disorder,
as operationally defined in DSM-III, was lower than
ex p e c t e d.
Freedman, Bucci, and Elkowitz

(1982) conducted a pilot

study of 166 chronically ill family practice geriatric
patients living in the community in order to assess the
prevalence of depression in this group.

The investigation

was conducted in a single general practice facility through
an agreement with a collaborating physician.

The population

consisted largely of first and second generations of Italian
and Jewish descent.

The physician was especially interested

in geriatric medicine.

His practice included a large

population of patients 60 years or older who were seen on a
regular basis.

A survey of case records was conducted to

determine the distribution of patients by age, sex, and
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primary chronic illness.

The two illnesses most frequently

encountered in this practice were hypertension and
arthritis.

All subjects within the selected chronic disease

categories were included in the sample.

The study sample

included 108 women and 58 men whose ages ranged from 60 to
86 years.
Assessment of depression was based on the Zung
Depression Status Inventory (DSI), a 20-item semi-structured
interviewer-rated inventory, administered by the physician.
For the total sample visiting their family physician for a
routine examination and without diagnosed psychiatric
impairment, the mean DSI score was 49.8, while a fourth of
the sample had DSI scores of 60 or above.

According to

Zung, DSI scores of 50 or above in the population at large
may be interpreted as indicating the presence of a
depressive psychopathologic disorder.

A score of 50-59 is

associated with minimal to mild depression,
moderate to severe depression,

60-69 with

70 or above with severe

depression, and lower than 50 with normal mental status.
Depressive symptom levels also were traced in
successive age groups.

Five successive age groups were

considered, divided according to 5-year intervals from 60
years of age, with the eldest group including all subjects
80 years or older.

Overall the data indicated a

relationship between depressive symptoms and aging.
Analysis of variance of the mean DSI totals showed an
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overall sex effect, with females consistently showing higher
mean scores

[F(3,

166) = 16.78, p = .001].

There was a

significant age-by-sex interaction [F(3, 166) = 3.92, p =
.005] making it necessary to examine separately the patterns
of depression in men and women.

Significant age effects

were found for both men [F(3, 58) = 2.75, p [F(3, 108) = 2.62, p = .04].

.04] and women

Women showed peak symptom

levels in the 65- to 69-year age range and men in the
subsequent 70- to 74-year age range (Freedman et al.,

1982).

The major conclusion drawn from the study was that
elderly community residents without recognized psychiatric
impairment had a depression level similar to the borderline
level indicating the presence of psychiatric illness among
the population as a whole.

Furthermore, a fourth of these

elderly residents had DSI scores that would be classified as
indicating moderate to severe depression;

this proportion

rose to more than half in the peak 65- to 69-year age range.
A recommendation for further study was to use the general
practitioner's office as a mental health screening locale.
Borson et al.

(1986) assessed the prevalence of

depressive symptoms in a primary care clinic in a Veterans
Administration Medical Center.

All patients aged 6 0 and

over served by this clinic were selected for this study
(N = 917).

Each patient was mailed a consent form for

participation, a demographic data checklist, and the Zung
Self-Rating Depression Scale (SDS).

A total of 447

(49%)
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returned all three items.

Forty-one patients were excluded

from analysis due to incomplete data sets.

Twenty-four

percent of the total sample (99 of 406) scored above 60 on
the SDS index.

Index scores of 60 or greater are strongly

suggestive of clinical depression in older populations.
The SDS index score for the depressed group was 66.3 + 4.4
(M + S D ) , and for the nondepressed group, 43.8 + 6.7.
The age range of the sample was 60 to 91 years.

Fifty-

eight percent of the patients were between 60 and 69 years
of age, 23% were 70 to 79, and 19% were over 80.
scores showed no significant age effects.

Mean SDS

Demographic

variables that differentiated patients with high depression
scores from those with low scores were marital separation or
divorce (p = .008) and inability to work because of medical
disability.

Widowhood and voluntary retirement were less

common in the depressed than in the nondepressed group
(p < .01).
of men

Social isolation, as reflected by proportions

who lived alone, also failed to differentiate the

depressed from the nondepressed group.

Correlations between

SDS scores and income or educational level were not
significant.

Thirty different medical complaints and

disorders were specified in the data base.

These problems

included the common chronic diseases of late life, such as
hypertension, heart disease, chronic lung disease,
arthritis, and diabetes.

stroke,

Of this large group of health

problems, only chronic obstructive lung disease appeared to
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be associated with high depression scores, but this
association was not statistically significant (p = .09)
(Borson et al.,

1986).

These findings indicated that significant depressive
symptoms were present in about one quarter of older men with
chronic disease.

The calculated probable prevalence of

major depression suggests that approximately 10% of these
chronically ill men were experiencing a syndromal
depression.

Such depressive episodes are likely to be

relieved by specific antidepressant pharmacotherapy or by
psychotherapy.

Some patients reporting significant problems

with depression are likely to be experiencing transient
affective disturbances which will improve without
professional attention.

For others, self-reported

depressive symptoms reflect another nonaffective disorder,
such as side effects of medication prescribed for treatment
of medical illness.
Recommendations by the authors included further
research to define the extent of depression among elderly
medical patients with chronic illness.

Such research

promises benefits in improved quality of life and may
decrease functional impairments from chronic disease such as
side effects of medications.
As previously stated, only one study could be found
with the specific purpose of identifying drugs that were
related to depression.

Higginbottom (1986) conducted a
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descriptive correlational study designed to identify drugs
significantly related to depression.

Data were collected

from 37 subjects who were over the age of 50, oriented to
person, and took at least one drug for medical illness.
The sample was obtained from a local medical clinic in a
rural northeast county in Mississippi.

All subjects were

administered the Zung Self-Rating Depression Scale and a
Drug Information Sheet.

The drugs were categorized and

compared with the depression score.

The results

demonstrated significance between three drug categories
and depression (at the .05 level).
(r

= .3805), antidepressants

relaxers

(r = .2789).

These were antianginal

(r = .3621), and muscle

Based upon the findings of this

study, the following recommendations were made:

(a)

conduction of a similar study controlling for the presence
of a depressive life event and (b) conduction of a
longitudinal study to investigate the long-term effects of
various drugs and drug regimes.
In summary, the cited studies documented the prevalence
of depression of elders living independently in the
community.

Two of these studies examined the interaction of

emotional and physical conditions.

In Freedman et a l .'s

(1982) study, hypertension was the major diagnosis for 57
subjects;

arthritis and hypertension were equally dominant

for 43 subjects.

A fourth of this sample had depression

scores indicating moderate to severe depression.

In Borson
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et a l .'s (1986) study, 406 subjects had chronic diseases of
late life including hypertension and heart disease.

One

quarter of these older men had scores indicating significant
depression.

Therefore, the association has been made

between chronic illness and depressive symptomatology.
However,

little research has examined the medication that

chronically ill elders ingest and their level of depression.
Borson et al.

(1986) suggested that depressive symptoms may

reflect another nonaffective disorder such as side effects
of medication.

Therefore, more research is needed

concerning medication ingestion by elders and level of
d e p r ession.

Chapter III
The Research Design
The type of research employed in this study was
descriptive ex post facto to determine the effects of
antihypertensive and cardiac drugs and level of depression
in community-based elders.

The descriptive design has as

its main objective "the accurate portrayal of the
characteristics of persons, situations, or groups and the
frequency with which certain phenomena occur"
Hungler,

1983, p. 528).

(Polit &

In ex post facto study designs the

investigator attempts to study something after the fact.
Instead of introducing or manipulating an independent
variable, the investigator selects subjects who have
undergone some life experience.

When the independent

variable cannot be manipulated and random assignment of
subjects to control and experimental groups are not
possible, an ex post facto study is appropriate and
worthwhile

(Wilson,

1989).

Variables
The independent variable in this study was the use
of antihypertensive drugs or cardiac drugs, or both
antihypertensive and cardiac drugs used by community-based
18
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elders.

The dependent variable in this study was the level

of depression in the elderly subjects as determined by the
Brink Geriatric Depression Scale.
age and type of drug regime.

Controlled variables were

Intervening variables could

have included previous episodes of depression not medically
induced, the participant's level of anxiety, and mental and
physical states at the time of testing.
Limitations
Three limitations of the study design were identified
that prevented generalization.

The fact that the subjects

are over 55 years of age limits generalization to young
adults.

Also, the fact that the study was limited to three

counties prohibits generalization to other geographic areas.
Thirdly, the fact that only antihypertensive and cardiac
drugs were studied prohibits generalization to other classes
of drugs with the side effect of depression.
Setting, Population, and Sample
The setting of this study was a rural tri-county area
of Northeast Mississippi whose residents use one family
practice physician’s office.

This practice includes a large

clientele with an average of 80 to 90 clients seen per
office day.

Client ages range from newborns to 90 years

plus with the majority being 55 years and older.

Of these

elders, the majority are treated for chronic illness,
including hypertension, diabetes, and heart disease.
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The population consisted of clients 55 and older who
were currently using antihypertensive and cardiac drugs and
receiving health care at the medical clinic.

The research

sample for this study was one of convenience and consisted
of all elderly clients who were present on the days of data
collection and agreed to participate in the study.
were divided into four groups.

Subjects

Group 1 consisted of elders

taking neither antihypertensive nor cardiac drugs.

Group 2

consisted of elders taking antihypertensive drugs only.
Group 3 consisted of elders taking cardiac drugs only.
Group 4 consisted of elders taking both antihypertensive and
cardiac drugs.

Data were collected from participants during

the months of April and May 1990.

The sample size was 40.

Data Gathering Process
Approval from the Committee on Use of Human Subjects in
Experimentation of Mississippi University for Women (see
Appendix A) was obtained.

The medical clinic physician was

contacted, and the purpose and methodology of the study were
explained.

The agency consent form was signed at this time

(see Appendix B ) .

Permission was obtained to use the Brink

Geriatric Depression Scale (see Appendix C ) .

The

physician's clinic was visited one day prior to testing
dates to select potential research participants.

The next

day the researcher approached clients on an individual basis
in the waiting room and explained the purpose of the study.
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The participants were assured that all information would be
treated as confidential.

At this time written consent was

obtained from the participants

(see Appendix D ) .

The subjects then were asked to accompany the
researcher to a treatment room in the clinic.

Each

participant was administered the Drug Information Sheet (see
Appendix E) and the Brink Geriatric Depression Scale (see
Appendix F ) .

The researcher was present to assist each

participant individually as needed for recording present
medications and to answer any questions regarding the study.
After completion, the questionnaires were stapled together
and placed in an envelope.
A pilot study was conducted with five research subjects
to detect any unforeseen problems with this research
process.

No changes of the instruments, data collection

techniques, or characteristics of the sample were necessary.
Therefore, these subjects were included in the total sample.
Instrumentation
Each participant completed the Drug Information Sheet
which consists of six demographic and social questions
including age, sex, race, marital status, and medical
diagnosis.

A section also was included to list all

prescribed medicines and nonprescribed medicines.

This

instrument was researcher-designed and has no established
reliability or validity.

However, since only factual
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information was asked,

it is considered valid within the

confines of this study.
Each participant also completed the Brink Geriatric
Depression Scale (GDS).

The purpose of the GDS is to

measure the level of depression in the elderly population.
It is a 30-item assessment scale with yes/no answers
designed for geriatric clients and based almost exclusively
on psychologic discriminators.

Directions for

administration and scoring are clear and complete.
participant simply reads and circles the answer.
questions,

The
Of the 30

20 indicate the presence of depression when

answered positively (2, 3, 4, 6, 8, 10, 11, 12, 13, 14, 16,
17,

18, 20, 22, 23, 24, 25, 26, 28) while the other 10 (1,

5, 7, 9, 15, 19, 21, 27, 29, 30) indicate depression when
answered negatively.

Answers were scored as follows:

0 to

10 = normal,

11 to 20 = mild depression,

21 to 30 = severe

depression.

This scale is markedly effective in determining

the presence of significant depression as the confounding
features

(physical complaints,

deemphasized.

libido, and appetite)

are

The length, level of difficulty, and amount

of time needed to complete the instrument were acceptable
for the intended subjects
1988 ; Ebersole & Hess,

(Brink & Yesavage,

1983; Dreyfuss,

1985).

The GDS was tested for reliability and validity and
compared with the Hamilton Rating Scale for Depression
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(HRS-D) and the Zung Self-Rating Depression Scale (SDS).
Two groups of geriatric subjects were chosen for the
validation phase of the GDS.

The first group (n = 40)

consisted of elderly persons with no history of mental
illness.

The second group (n = 60) consisted of elderly

persons under treatment for depression.

The subjects were

given a clinical interview which involved a rating of the
HRS-D and administration of the GDS and the SDS.

Four

measures of internal consistency were computed for each of
the three depression scales.
the items of the GDS was

The mean correlation between

.56, suggesting that all of the

items on this scale do, in fact, measure a common latent
variable.
GDS was

The mean intercorrelation among items from the

.36; the computed values for the SDS and HRS-D were

.25 and .34, respectively.

These values are in a range

necessary for a high degree of internal consistency for each
scale as a whole.

Cronbach's alpha coefficient was utilized

in order to provide an overall measure of the internal
consistency of the GDS.
coefficient was

The computed value of the alpha

.94, suggesting a high degree of internal

consistency for the GDS.

Using the split-half reliability

method, the reliability coefficients for the GDS, SDS, and
HRS-D were found to be .94, 81, and .82, respectively (Brink
& Yesavage,

1983).

The primary test of the validity of the GDS as a
measure of depression was provided by the classification of
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subjects as normal, mildly depressed, or severely depressed.
An analysis of variance was conducted in which the
classification variable served as a between-subjects factor
while the subjects'

total scores on the GDS served as the

dependent measure.

Similar analyses provided evidence for

each of the scale's validity.

In each analysis the main

effect for the classification variable was highly
significant.

Respective F scores were 99.48 for the GDS,

44.75 for the SDS, and 110.63 for the HRS-D.

These findings

then provide evidence for the validity of the GDS as a
measure of depression as well as validating the SDS and
HRS-D (Brink & Yesavage,

1983).

Data Analysis
Data for the null hypothesis were analyzed using the
analysis of variance (ANOVA).

This statistical method was

appropriate because four groups were compared.

Data for

hypotheses 2, 3, 4, 5, and 6 were analyzed using the t test.
The t test was an appropriate statistical test with these
data because two groups were compared.

Chapter IV
Results of the Study
The purpose of this study was to determine the
effects of anti-hypertensive and cardiac drugs and level
of depression in community-based elders.

The type of

research employed in this study was descriptive ex post
facto.

The subjects were divided into four groups according

to their drug usage, and data were analyzed using the one
way analysis of variance (ANOVA) and the directional t test.
The findings of this study are presented in this chapter.
Sample
The total sample was divided into four gro u p s .
The groups were divided as follows :

(a) Group 1, elders

taking neither antihypertensive or cardiac drugs;
2, elders taking antihypertensive drugs only;

(b) Group

(c) Group 3,

elders taking cardiac drugs alone; and (d) Group 4, elders
taking both antihypertensive and cardiac drugs.

The

characteristics of these groups can be found in Appendix G.
The sample was comprised of 40 subjects ranging in age
from 55 to 88 years with a mean age of 70.
(50%) married,

There were 20

13 (33%) widowed, and 7 (17%) single
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subjects.

Sixteen (40%) of the sample were male and 24

(60%) were female.

Thirty (75%) of the sample were white,

and 10 (25%) were black.
The subjects'

scores on the Brink Geriatric Depression

Scale ranged from 1 to 16 with an average of 10.4.

There

were 15 (37%) subjects who scored normal, and 25 (63%)
subjects who scored mildly depressed.
Group 1 .

Group 1 was the control group and consisted

of 10 elders taking neither antihypertensive nor cardiac
drugs.
62.

The age range was 55 to 72 years with a mean age of

Five (50%) of these subjects were male and 5 (50%) were

female.

There were 6 (60%) married and 4 (40%) widowed.

Eight (80%) of these subjects were white, and 2 (20%) were
black.

The subjects'

scores on the Brink Geriatric

Depression Scale ranged from 1 to 14 with an average score
of 7.3.

There were 7 (70%) subjects who scored normal and

3 (30%) who scored mildly depressed.
Group 2 .

Group 2 consisted of elders taking

antihypertensive drugs only.

The age range was 55 to 79

years with a mean age of 68.

Four (40%) of these subjects

were male and 6 (60%) were female.

There were 8 (80%)

married and 2 (20%) widowed subjects.

Seven (70%) of these

subjects were white and 3 (30%) were black.

The subjects'

scores on the Brink Geriatric Depression Scale ranged from 6
to 14 with an average of 10.1.

There were 3 (30%) subjects

who scored normal and 7 (70%) who scored mildly depressed.
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Group 3 .
drugs only.
age of 78.

Group 3 consisted of elders taking cardiac

The age range was 60 to 88 years with a mean
Four (40%) of these subjects were male and 6

(60%) were female.

There were 4 (40%) widowed,

single, and 1 (10%) married subjects.

5 (50%)

Seven (70%) of these

subjects were white and 3 (30%) were black.

The subjects'

scores on the Brink Geriatric Depression Scale ranged from 9
to 16 with an average of 12.1.

There were 3 (30%) subjects

who scored normal and 7 (70%) who scored mildly depressed.
Group 4 .

Group 4 consisted of elders taking both

antihypertensive and cardiac drugs.
80 years with a mean age of 72.

The age range was 60 to

Three (30%) of these

subjects were male, and 7 (70%) of these subjects were
female.

There were 2 (20%) single, 5 (50%) married, and 3

(30%) widowed subjects.

Eight (80%) of these subjects were

white and 2 (20%) were black.

The subjects'

scores on the

Brink Geriatric Depression Scale ranged from 9 to 14 with an
average of 12.1.

There were 2 (20%) subjects who scored

normal and 8 (80%) who scored mildly depressed.
Data Analysis
Hypothesis 1 .

The first hypothesis was that there

would be no difference in mean depression scores among the
following:

Group 1, elders taking neither antihypertensive

or cardiac drugs; Group 2, elders taking antihypertensive
only; Group 3, elders taking cardiac drugs alone; and Group
4, elders taking a combination of antihypertensive and
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cardiac drugs.

The mean scores for these subjects were :

Group 1 , 7.3; Group 2 , 10.1; Group 3, 12.1; and Group 4,
12.1.

Scores were analyzed using the one-way analysis of

variance (ANOVA).

Since F(3, 40) = 5.036, p = .037, the

null hypothesis was rejected.

These data can be found in

Table 1.
Table 1

ANOVA

df

Source

SS

MS

3

154.8000

51.6000

Within groups

36

368.8000

10.2444

Total

39

523.6000

Between groups

F
5.036*

p = > .05.
Hypothesis 2 .

The second hypothesis was that

community-based elders taking antihypertensive drugs would
experience a significantly higher level of depression than
elders not taking both antihypertensive and cardiac drugs.
The mean scores for these subjects were :
Group 1, 7.3.
test.

Group 2, 10.1 and

Scores were analyzed using the directional t

Since t (20) = 1.956, p = .03, the second hypothesis

was accepted. These data can be found in Table 2.
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Table 2
Comparison of Community-Based Elders Taking Antihypertensive
Drugs and the Elder Control Group Using the t Test

n

SD

M

Group 2

10

10.1

2.96

Group 1

10

7.3

4.79

1.956*

*p = > .05.
Hypothesis 3 .

The third hypothesis was that elders

taking cardiac drugs would experience a significantly higher
level of depression than elders not taking both
antihypertensive and cardiac drugs.
these subjects were:

The mean scores for

Group 3, 12.1 and Group 1, 7.3.

Scores also were analyzed using the directional t test.
Since t (20) = 3.353, p = .001, the third hypothesis was
accepted.

These data can be found in Table 3.

Table 3
Comparison of Community-Based Elders Taking Cardiac Drugs
and the Elder Control Group Using the t Test

n

M

SD

Group 3

10

12.1

.72

Group 1

10

7.3

4.79

t

3.353*

p = > .05
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Hypothesis 4 .

The fourth hypothesis was that elders

taking both antihypertensive and cardiac drugs would
experience a significantly higher level of depression than
elders taking antihypertensive drugs alone.
for these subjects were :

The mean scores

Group 4, 12.10 and Group 2, 10.10.

Scores were analyzed using the directional t test.

Since

t (20) = 1.397, p = .086, the fourth hypothesis was rejected.
These data can be found in Table 4.
Table 4

and Cardiac Drugs and Elders Taking Antihypertensive Drugs
Alone Using the t Test

n

M

SD

Group 4

10

12. 10

2.02

Group 2

10

10. 10

2.96

t

1.397

Hypothesis 5 .

The fifth hypothesis was that elders

taking both antihypertensive and cardiac drugs would
experience a significantly higher level of depression than
elders taking cardiac drugs alone.
these subjects were :

The mean scores for

Group 4, 12.10 and Group 3, 12.10.

Scores were analyzed using the directional t test.

Since
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t(20) = .000, p = .50, the fifth hypothesis was rejected.
These data can be found in Table 5.
Table 5

and Cardiac Drugs and Elders Taking Cardiac Drugs Alone
Using the t Test

n

M

SD

Group 4

10

12.10

2.02

Group 3

10

12.10

2.28

t

.000

Hypothesis 6 .

Finally, the sixth hypothesis was that

elders taking both antihypertensive and cardiac drugs would
experience a significantly higher level of depression than
elders taking neither antihypertensive nor cardiac drugs.
The mean scores for these subjects were :
Group 1, 7.3.
test.

Group 4, 12.10 and

Scores were analyzed using the directional t

Since t (20) = 3.353, p = .001, the sixth hypothesis

was accepted.

These data can be found in Table 6.
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Table 6
Comparison of Community-Based Elders Taking Antihypertensive
and Cardiac Drugs and Elders Taking Neither Antihypertensive
Nor Cardiac Drugs Using the t Test

n

M

SD

Group 4

10

12.10

2.02

Group 1

10

7.30

4.79

t

3.353*

fp = > .05

Chapter V
Outcomes
Summary
The purpose of this descriptive ex post facto study was
to determine the effects of antihypertensive and cardiac
drugs on the level of depression in community-based elders.
Roy's Adaptation Model provided the theoretical framework
for this study.

Data were collected using the Brink

Geriatric Depression Scale and the Drug Information Sheet.
These questionnaires were administered to 40 subjects ages
55 and older who were taking antihypertensive and/or cardiac
drugs or neither antihypertensive nor cardiac d r u g s .
The null hypothesis guiding this study contended that
there would be no difference in mean depression scores among
the following groups:

(a) community-based elders taking

neither antihypertensive nor cardiac drugs,

(b) community-

based elders taking antihypertensive drugs alone,

(c)

community-based elders taking cardiac drugs alone, and
(d) community-based elders taking a combination of
antihypertensive and cardiac d r u g s .
using the ANOVA.

Data were analyzed

Since the result was significant at the

.05 level, the researcher rejected the null hypothesis.
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The researcher further hypothesized the following:
Ha^:

Community-based elders taking antihypertensive

drugs would experience a significantly higher level of
depression than community-based elders taking neither
antihypertensive nor cardiac d r u g s .
Ha^ :

Community-based elders taking cardiac drugs would

experience a significantly higher level of depression than
community-based elders not taking antihypertensive and
cardiac d r u g s .
Ha^ ;

Community-based elders taking antihypertensive

and cardiac drugs would experience a significantly higher
level of depression than community-based elders taking
antihypertensive drugs alone.
Ha^;

Community-based elders taking antihypertensive

and cardiac drugs would experience a significantly higher
level of depression than community-based elders taking
cardiac drugs alone.
Ha^ :

Community-based elders taking antihypertensive

and cardiac drugs would experience a significantly higher
level of depression than community-based elders taking
neither antihypertensive nor cardiac drugs.
Data were analyzed using the directional
t test.
the

(one-tailed)

Since Hypotheses 2 , 3, and 6 were significant at

.05 level, the researcher accepted these hypotheses.

Hypotheses 4 and 5 were not significant;
researcher rejected these hypotheses.

therefore,

the
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Discussion, Conclusions, and Implications
The findings from this study indicated the elders who
took antihypertensive and/or cardiac drugs experienced a
significantly higher level of depression as compared to
elders who did not take antihypertensive nor cardiac drugs.
These results support Higginbottom's (1986)

finding that

depression and use of antianginal agents were correlated.
These current findings suggest that cardiac drugs alone
appear to have significant effects on the elder's level of
depression.

However, reasons for depression other than

medication should be considered.

The presence of a chronic

illness or the seriousness of a cardiac disease could be
considered a cause of the elder's depression.

In addition,

the average age of the subjects taking only cardiac drugs
was 77.6 years as compared to 62 years in the control group.
Perhaps, as a result of their developmental stage the older
participants were undergoing adjustment to losses not
encountered by the younger sample.

This age finding does

not support Freedman et a l .'s (1982) study where women
showed peak depression symptoms in the 65-69 year range and
men in the subsequent 7 0-74 year range.

These suggestions

and findings support the need for more research examining
other chronic illnesses and level of depression and age
groups and level of depression.
Utilizing this information and Roy's Adaptation Model,
the Geriatric Nurse Clinician (GNC) should carefully assess
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for signs and symptoms of depression in all elders taking
cardiac drugs.

These elders should be considered to be at a

higher risk for depressive symptomatology.

Depression

caused by pharmacotherapeutic agents signifies adaptation
failure.

The goal of the GNC is to identify maladaptive

responses and their causes and to help bring about
adaptation resulting in a better quality of life for the
elder.
Antihypertensive drugs alone were found to have an
effect on level of depression; however, a combination of
antihypertensive and cardiac drugs appear to have a more
significant effect on level of depression.

No research was

found which either supported or refuted this finding.
Again, this level of depression may be the result of having
a combination of chronic illnesses or ingestion of multiple
medications.

Therefore, the need for research examining

chronic illnesses and level of depression in elders is
mandated.

Freedman et al.

(1982) and Borson et al.

examined elders with chronic illnesses

(19 86)

(arthritis,

hypertension, and heart disease) and depressive
symptomatology.

These current findings support the

association that has already been established between
chronic illnesses and depressive symptoms.

However,

findings of mild depression refute Freedman et al.
and Borson et a l .'s (1986)

these

(1982)

findings of moderate to severe

depression in community-based elders.

Since these findings
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utilized only 40 subjects from a small rural area,

further

research in another geographic area and with a larger sample
are needed to determine generalizabi1ity of the findings.
According to Riehl and Roy (1980),

focal stimuli are

stimuli immediately confronting the person.

In this

research pharmacotherapeutic agents are focal stimuli.
Therefore, the GNC should maintain a knowledge of the drugs
with the known side effect of depression.

The GNC can

prescribe medication in collaboration with a physician, so
discretion should be used in prescribing multiple drugs and
in prescribing and monitoring those drugs and level of
depression.

Education of other health care providers also

is needed concerning drug categories with the known side
effect of depression in order to minimize the risk of
pharmacotherapeutic depression.
Since depression affects the elder's functioning in all
adaptive modes and predisposes the elder to suicide, the GNC
should consult with the physician whenever possible to
adjust the medication regimen so that the risk of
pharmacotherapeutic depression can be minimized.

In the

event these medications cannot be avoided, the elder should
be counseled concerning side effects of medications and
signs and symptoms of depression.
Overall, elders in this study had scores indicating
mild depression.

Yet, each elder group under investigation

contained subjects who were not depressed, and the control
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group contained elders who were mildly depressed.

In the

control group (elders taking neither antihypertensive nor
cardiac drugs), 3 (30%) of the subjects scored mildly
depressed.

In Groups 2 and 3 (elders taking

antihypertensive or cardiac drugs),
depression scores.

3 (30%) had normal

In Group 4 (elders taking

antihypertensive and cardiac drugs), 2 (20%) of the subjects
had normal depression scores.

Therefore, not every elder

taking these medications experienced depression, and those
elders who took neither medication still experienced
depression.

It is important to note that depression scores

exhibited were only at the mild rather than moderate or
severe depression level.
Based on the conclusions of this study,
pharmacotherapeutic depression may or may not result when
antihypertensive and/or cardiac drugs are ingested.

In the

event that pharmacotherapeutic depression results, the GNC
should initiate measures in each of the adaptive modes for
helping the elder cope with depression and hopefully bring
about a more adaptive response.

Along with establishing a

therapeutic nurse-client relationship, antidepressant
medications may be in order.

Other interventions to assist

the elder in coping with depression include relaxation or
meditation techniques, exercise, new interests, and
diversional activities.

These actions may then lead to a

decrease in health problems caused by depression and a
better quality of life for elders.
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Recommendations
Based upon the findings of this study, the following
recommendations are made:
Research
1.

Conduction of a similar study including other

chronic illnesses and level of depression.
2.

Conduction of a similar study using age cohort

groups and level of depression.
3.

Conduction of a similar study to determine effects

of multiple medication ingestion and level of depression.
4.

Replication of this study in another geographic

area using a larger sample size to determine
generalizability of findings.
Nursing
1.

Maintenance of an awareness for the drug categories

with the known side effect of depression.
2.

Discretion in prescribing and monitoring those drug

categories with the known side effect of depression.
3.

Assessment of those elders who are taking

antihypertensive and/or cardiac drugs for depressive
symptomatology.
4.

Education of other health care providers concerning

drug categories with the side effect of depression.
5.

Education of the client concerning side effects of

medications and signs and symptoms of depression.
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Appendix B
Consent to Conduct Study
Research Study:
Effects of Antihypertensive and Cardiac Drugs and Level
of Depression in Community-Based Elders
My name is Angela Hays.

I am a registered nurse and

graduate student at Mississippi University for Women.

I am

studying medicines that may be related to depression in
older people.

The results of this study will be used by

health care providers to improve care for older people.
Health care providers will be able to prescribe a different
regimen of drugs that are not related to depression, thereby
helping older people lead a more meaningful life.

A copy of

the results of the study will be available at your request.
I would like written permission to use your clinic for
my study.

Assistance from your staff in data collection

will not be required, and your office routine will not be
affected.

Thank you for your time and assistance.

I hereby give permission for my patients to participate in
this study.
Date:
Date :

_________________________ Signed:__________________________
Researcher:

Appendix C
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Permission to Use Tool

27 Nov 89

T .L Brink, Ph.D. Editor
Clinical Gorontologlat
1103 Church Street
Redlsnda. CA 92374

Angela Hays. R.N.
P.O. B O X 393
Walthall, MS
39771
Dear Ms. Hayes ;
Enclosed is a copy of the scale you requested, complete with
scoring/administration Instructions, and even an annotated bib
liography. (Sorry, I do not have more reprints of the articles
listed in the bibliography.) I hereby grant permission to use in
your clinical work and research, but strongly suggest that you do
not alter the guidelines for administration and scoring (nor
delete items). If you will be trying to show a treatment effect,
I suggest that you start out with a clinically depressed sample.
If your sample size is small, I suggest the use of non-parametrie
statistics (e.g., Fisher Exact, Mann-Whitney, Sign Test,
Friedman, Kolmogorov-Smirnov).
Let me take this opportunity to tell you a little about the
journal that I edit. Clinical Gerontologist, now in its seventh
year, is for psychiatrists, psychologists, social workers, geria
tricians, nurses, and other counselors. Our editorial board in
cludes Manfred Rergener, Dolores Gallagher, v .a . Krai, Myrna
Lewis, Nancy Miller, Brice Pitt, Peter Rabins, Sir Martin Roth,
Jerome Yesavage, and other clinical gerontologists around the
world. CG covers topics such as dementia, depression, hypochon
driasis, paranoia, assessment, psychotherapy, psychopharmacology,
family counseling, and multi-disciplinary teams. What dis
tinguishes CG from some other journals in this field is an uncom
promising commitment to practitioner relevance. If you are not
yet a subscriber to CG, just contact the Haworth Press at
10 Alice Street, Binghamton, NY 13904-1580*
Perhaps you would like to author something for us. We have
three categories of writings: full-length articles (30%
acceptance rate), clinical comments limited to four typewritten
pages (70% acceptance rate) and reviews of books and other media
(90% acceptance rate). For all categories, you should submit four
copies, typewritten, double spaced, 'camera ready’ originals of
all charts, tables, diagrams, and remember to include a stamped,
self-addressed envelop if you want a rejected manuscript
returned* We prefer APA format.
How to contact me: FIRST CLASS MAIL TO MY ABOVE ADDRESS. If
you write me in Mexico, Stanford, or Haworth, I may get your
letter next month. If you send express mail or certified, they
d o n ’t leave it in my box, and I ’ll get in the next time I get
down to the post office. If you call m e , we trade telephone
messages for weeks without speaking directly to each other. So,
just send me a first class letter, please.
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Appendix D
Informed Consent Form
My name is Angela Hays.

I am a registered nurse and

graduate student at Mississippi University for Women.

I

am studying about medicines that may be related to your
feelings.

Although there will

the results of this study will

be no direct benefits to you,
be used by health care

providers to improve care for older people.

If you should

decide to help in this study, you will be asked to complete
two questionnaires.

One questionnaire asks for information

about you and your medicines.

The other questionnaire will

help to determine your mood at this time.
questionnaires will take about
complete.

The two

20 minutes or less to

No names will be used,

be destroyed after it is analyzed.

and this information will
If you should decide not

to help, your health care at this clinic will not be
affected in any way.
Thank you for your time and assistance.

Date;_____________________ Name :_____
Date :

Researcher
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Appendix E
Code
Drug Information Sheet
Age :
Sex:

Medical Diagnosis
Male

Female

Race :
_____ White
_____ Black
_____ Hispanic
_____ Oriental
Other
Marital Status : (Please check correct one)
_____
Single
_____
Married
_____
Widowed
_____
Separated
Divorced
List medicines that you are taking now that are ordered by
your doctor:

List any other medicines that you are taking now not ordered
by your doctor that you buy at the drug store, grocery
store, or convenience store.
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Appendix F
Code_________
Brink Geriatric Depression Scale
Choose the best answer for how you have felt over the past
week.
1.

Are you basically satisfied with your life?
Yes
No____

2.

Have you dropped many of your activities and interests?
Yes
No____

3.

Do you feel that your life is empty?

4.

Do you often get bored?

5.

Are you hopeful about the future?

6.

Are you bothered by thoughts you can't get out of your
head?
Yes____
No____

7.

Are you in good spirits most of the time?
Yes
No____

8.

Are you afraid that something bad is going
to happen to you?
Yes
No____

9.

Do you feel happy most of the time? Yes

Yes_____

Yes

No____

No___
Yes

Yes

No____

No________

10.

Do you often feel helpless?

No____

11.

Do you often get restless and fidgety?

12.

Do you prefer to stay at home, rather than
going out and doing new things?
Yes

Yes

No___
No____

13.

Do you frequently worry about the future?
Yes
No____

14.

Do you feel you have more problems with memory than
most?
Yes
No____

15.

Do you think it is wonderful to be alive now?
Yes
No
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No___

16.

Do you often feel downhearted and blue?

Yes____

17.

Do you feel pretty worthless the way you are now?
Yes
No____

18.

Do you worry a lot about the past? Yes

19.

Do you find life very exciting? Yes

20.

Is it hard for you to get started on new projects?
Yes
No____

21.

Do you feel full of energy?

22.

Do you feel that your situation is hopeless?
Yes
No____

23.

Do you think that most people are better
off than you are?
Yes
No____

24.

Do you frequently get upset over little things?
Yes
No____

25.

Do you frequently feel like crying?

26.

Do you have trouble concentrating? Yes

27.

Do you enjoy getting up in the morning?
Yes
No____

28.

Do you prefer to avoid social gatherings?
Yes
No____

29.

Is it easy for you to make decisions?

30.

Is your mind as clear as it used to be?

No____
No_________

Yes

No____

Yes

No
No__

Yes
Yes

No_
No
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Appendix G
Characteristics of the Research Sample by Groups

Subject

Age

Sex^

Race^

Marital
Status^

Group

Depression
Score^

Depre^ion
Group

Group 1
1

55

1

0

2

1

6

1

2

60

0

0

2

1

11

2

3

60

0

0

2

1

11

2

4

60

0

0

2

1

1

1

5

55

1

0

2

1

11

2

6

56

0

0

2

1

1

1

7

58

0

1

3

1

9

1

8

72

1

1

3

1

1

1

9

67

0

0

3

1

9

1

10

72

1

0

3

1

10

1

Group 2
11

79

1

0

3

2

6

1

12

72

1

0

3

2

12

2

13

55

1

0

2

2

6

1

14

67

1

0

2

2

12

2

15

72

1

1

2

2

14

2

Sex;
0 = Male, 1 = Female.
Race:
0 = W h i t ^ 1 = Black.
'Marital
Status:
1 = Single, 2 = Married, 3 = Widowed.
Group:
1 = Control, 2
^ Antihypertensive, 3
Cardiac, 4 = Antihypertensive and Cardiac.
^Depression Score.
Depression Group:
1 = Normal,
2 = Mildly
Depressed.
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Subject

Age

Marital
Status

Race

Sex

Depression
Score

Group

Depression
Group

16

72

0

1

2

2

11

2

17

60

0

0

2

2

6

1

18

65

1

0

2

2

11

2

19

68

0

0

2

2

12

2

20

69

0

1

2

2

11

2

Group 3
21

80

1

0

3

3

11

2

22

86

1

0

1

3

14

2

23

88

1

0

3

3

9

1

24

85

1

0

3

3

10

1

25

87

0

1

3

3

11

2

26

65

0

1

1

3

14

2

27

80

1

0

1

3

10

1

28

65

0

0

1

3

14

2

29

60

0

1

2

3

16

2

30

80

1

0

1

3

12

2

Group 4
31

60

0

0

2

4

12

2

32

67

1

0

2

4

13

2

33

72

1

0

1

4

14

2

34

65

1

0

2

4

14

2

35

80

0

0

2

4

9

1

36

75

1

0

1

4

11

2

37

72

0

1

2

4

14

2

38

80

1

1

3

4

9

1

39

72

1

0

3

4

14

2

40

80

1

0

3

4

11

2

